Showing results (401-410 of 501) with videos related to

Sort By:
Pageof 51
The American Journal of Medicine|February 1, 1993
Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet)M A Polis, M D deSmet, B F Baird, et al.
The Journal of Clinical Investigation|August 1, 1993
Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160J A Kovacs, M B Vasudevachari, M Easter, et al.
Annals of Internal Medicine|July 1, 1982
Leukocyte-derived interferon (alpha) in human breast carcinoma. The American Cancer Society phase II trialE C Borden, J F Holland, T L Dao, et al.
The Journal of Infectious Diseases|June 1, 1996
Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infectionS Sei, H Akiyoshi, J Bernard, et al.
The New England Journal of Medicine|March 9, 1975
Health-care workers positive for hepatitis B surface antigen. Are their contacts at risk?H J Alter, T C Chalmers, B M Freeman, et al.
Pediatrics|November 1, 1994
Clinical and pharmacokinetic evaluation of long-term therapy with didanosine in children with HIV infectionB U Mueller, K M Butler, V L Stocker, et al.
Journal of Clinical Apheresis|January 1, 1991
Stimulatory effect of counterflow centrifugal elutriation in large-scale separation of peripheral blood monocytes can be reversed by storing the cells at 37 degrees CT G Abrahamsen, C S Carter, E J Read, et al.
Cancer|March 1, 1978
Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapseF R Appelbaum, A B Deisseroth, R G Graw, et al.
The Journal of Pediatrics|May 1, 1994
Orally administered clarithromycin for the treatment of systemic Mycobacterium avium complex infection in children with acquired immunodeficiency syndromeR N Husson, L A Ross, S Sandelli, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2000
Combination therapy with amprenavir, abacavir, and efavirenz in human immunodeficiency virus (HIV)-infected patients failing a protease-inhibitor regimen: pharmacokinetic drug interactions and antiviral activityJ Falloon, S Piscitelli, S Vogel, et al.
Pageof 51